PATENT CLAIM ANALYSIS

Application Number: 16011239
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to compositions comprising exosomes isolated from hASC and their use in a method of treating brain injury in a subject.

Claim (Index 2):
The method of  claim 1 , wherein the composition further comprises insulin.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14602945', '14406400', '14420680', '15432172', '14669454']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7509241325176514
- 35 USC 102 Novelty (BERT): 0.514123338460953
- Combined Prediction Score: 0.7272440531119817
- Mean Citation Score: 202.620706
- Max Citation Score: 235.80537
- Similarity Product: 136.63738213481605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test